Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 16, 2022 1:00 PM - Nov 16, 2022 5:00 PM

5th DIA Health Economics and Outcomes Research (HEOR) Workshop

Overview

This workshop will be conducted in Japanese Language only.

View the Program in Japanese

Program Committee

Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan
Toshihiko Aranishi, PhD Research Scientist, Health Outcomes/Health Technology Assessment
Eli Lilly Japan K.K, Japan
Mariko Hirozane, PhD Associate director, Policy intelligence department, Integrated Market Access Div
Janssen Pharmaceutical K.K. , Japan
Shinya Ohno, PhD, MPH Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan
Akihito Uda, MPH HEOR Group, Market Access and Public Affairs Division
Novartis Pharma K.K., Japan
Hisashi Urushihara, DrPH Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan
Kentaro Yamato, RPh Head of HEOR/RWE, Medical Affairs
Otsuka Pharmaceutical Co., Ltd., Japan
Keisuke Yoshihara, PhD, MSc HEOR Research Associate
Bayer Yakuhin, Ltd., Japan
Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
Gilead Sciences K.K., Japan
Shinzo Hiroi, PhD, MPH, RPh, PMP Head of Global Medical Affairs
Shionogi & Co., Ltd., Japan
Yuta Kasai Japan-Asia Clinical Development 2
Astellas Pharma Inc., Japan
Akiko Nishioka Clinical Research Associate, Clinical Operation
Novartis Pharma K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions

Download

Have an account?